Mechanisms of amine accumulation in, and egress from, lysosomes. - Wikidata - wikimedia - TriplyDB

Mechanisms of amine accumulation in, and egress from, lysosomes.

Mechanisms of amine accumulation in, and egress from, lysosomes.

http://www.wikidata.org/entity/Q34726610

about

Molecular imaging of intracellular drug-membrane aggregate formation Drug induced phospholipidosis: an acquired lysosomal storage disorder Giant Lysosomes as a Chemotherapy Resistance Mechanism in Hepatocellular Carcinoma Cells Identification of hepatic phospholipidosis inducers in sandwich-cultured rat hepatocytes, a physiologically relevant model, reveals altered basolateral uptake and biliary excretion of anionic probe substrates Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport.Zn(II)-coordination modulated ligand photophysical processes - the development of fluorescent indicators for imaging biological Zn(II) ions Anticancer activity expressed by a library of 2,9-diazaperopyrenium dications.Selective N-Hydroxyhydantoin Carbamate Inhibitors of Mammalian Serine Hydrolases A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease.Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells).Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver.pH-Responsive Triblock Copolymeric Micelles Decorated with a Cell-Penetrating Peptide Provide Efficient Doxorubicin Delivery Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications.Photoluminescence imaging of Zn(2+) in living systems.Structure-Activity Relationships and Kinetic Studies of Peptidic Antagonists of CBX Chromodomains.Long Receptor Residence Time of C26 Contributes to Super Agonist Activity at the Human β2 Adrenoceptor.Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance.Pigmented-MDCK (P-MDCK) cell line with tunable melanin expression: an in vitro model for the outer blood-retinal barrier First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in Vitro Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery.Preclinical Pharmacological Development of Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.A lysosome-specific two-photon phosphorescent binuclear cyclometalated platinum(II) probe for in vivo imaging of live neurons.

P2860

Q24635290-431501E9-4A59-4892-9256-55F89FF179EA Q26864959-1A8F85BE-CDC4-456B-8428-DE51C4574673 Q27321292-99F0D49C-C8B0-42E9-AD89-8149689B2199 Q33686976-6889CC33-F3D2-42F9-ADB4-A6A9213A27FC Q33709666-C22CA6F4-5431-4B32-BDB4-B0986A371D36 Q33951488-9AB9240C-FAE9-46C9-A000-5EBEC936A970 Q35130142-742719BB-586D-4E20-B8E7-706607AB88DE Q35676731-74536C24-4908-4A34-B844-B7F56BDDC9B1 Q36586194-6744FB4A-EBDA-41B7-BC4F-574E31722AA2 Q36658341-B59BCBF7-2478-4908-8B20-359EA9823E75 Q36717186-B9A4B009-CC2E-4521-9DDF-1F47DEC14975 Q36775577-9E045B17-3D08-4282-8FA9-F4BB3772B9D9 Q37474912-7F081C01-B900-4E76-9684-F85A4556858B Q38012166-46839323-7145-478C-BECE-A160964F9FC9 Q38369331-43527FA3-704D-4394-B530-6115FBC529A5 Q38749422-AE9C55F7-B3DB-4006-BF34-3A199A7E9A29 Q38803217-E4BBEC4A-840C-4D08-8214-6321E1A1CF05 Q38924917-15464106-58C1-449E-9CEA-F0C9BD093825 Q39273066-E53BE838-DC2B-4E0C-8BF9-459C3977A89F Q39671646-FB0A9964-7625-4C89-83D6-C751E39A4A98 Q41256404-66726B65-9CDD-4080-BB6E-E8E82CDD4246 Q47548651-E67DEAF9-6175-423E-9498-6D224B00849F Q48354981-E37974AD-CCB1-41D3-BBBA-2C6689DEBF8D Q50624716-98A9633D-38AF-43BC-BE49-30D7299FE9E0

P2860

Mechanisms of amine accumulation in, and egress from, lysosomes.

http://www.wikidata.org/entity/Q34726610

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Mechanisms of amine accumulation in, and egress from, lysosomes.

@ast

Mechanisms of amine accumulation in, and egress from, lysosomes.

@en

Mechanisms of amine accumulation in, and egress from, lysosomes.

@nl

type

label

Mechanisms of amine accumulation in, and egress from, lysosomes.

@ast

Mechanisms of amine accumulation in, and egress from, lysosomes.

@en

Mechanisms of amine accumulation in, and egress from, lysosomes.

@nl

prefLabel

Mechanisms of amine accumulation in, and egress from, lysosomes.

@ast

Mechanisms of amine accumulation in, and egress from, lysosomes.

@en

Mechanisms of amine accumulation in, and egress from, lysosomes.

@nl

P1433

Q34726610-CD118DF2-B7B6-433C-B4F5-D342E890761E

P1476

Q34726610-9EE151C3-6C5F-4A45-94C8-7E9F01E8373E

P2093

Q34726610-040B5E66-E5AF-4426-AD76-993278D8F406

Q34726610-3ACA433A-0DC3-43BB-9B14-F398777D66B5

Q34726610-5C00FF30-6563-4D22-8E08-00877C1EFE9F

Q34726610-755A41A9-A7B4-4F2E-BDC9-59DADC79E71A

P2860

Q34726610-0211F756-4606-4CA4-82F7-C96E328EDFF2

Q34726610-0318EF8C-A00F-41F4-BBC2-413033CA6C92

Q34726610-0ABAE005-7B56-45B4-96C6-B3D2104E787C

Q34726610-11B9761E-D746-41D3-BE01-C05E0BC14C0C

Q34726610-13D9B04C-3F57-421C-BD06-225A065B4646

Q34726610-1DBB197A-8630-430A-AFE0-CA1791ED3949

Q34726610-20E33DB8-C53C-4084-8F3C-0C6BB00EEF75

Q34726610-21EE9364-602A-405D-B25E-D9F461C1D140

Q34726610-22AC5C98-A729-4BAE-86D9-136A177F53C0

Q34726610-2BAC3FB8-FD31-43B6-BEBB-2DD186AAD23E

P304

Q34726610-658D7627-5C4E-436E-B0A2-EC11A48A064F

P31

Q34726610-925F82CB-2A4E-487C-8CD8-EEC8B9B5F81E

P356

Q34726610-FAC4806C-1555-43CD-BAB2-F38C584BA038

P433

Q34726610-A281C0B6-3AC6-4AAE-AA85-CC3CF6382AED

P478

Q34726610-D5711E1A-3663-49DF-951E-95D5B8F218A7

P577

Q34726610-45941D90-A6E4-4FB2-85A9-4D5DD122CD83

P5875

Q34726610-FBD513F0-A3A0-4026-BA36-31B089362008

P698

Q34726610-0518A015-45CB-4226-A124-EB266D4403F7

P932

Q34726610-216F29BF-E458-4B44-B362-C4BB8211C5F6

P356

P1433

P1476

Mechanisms of amine accumulation in, and egress from, lysosomes.

@en

P2093

Jeffrey P Krise

http://www.w3.org/2001/XMLSchema#string

Roger A Rajewski

http://www.w3.org/2001/XMLSchema#string

Ryan S Funk

http://www.w3.org/2001/XMLSchema#string

Stephen D B Goldman

http://www.w3.org/2001/XMLSchema#string

P2860

Quantitative modeling of selective lysosomal targeting for drug design

Transmembrane molecular pump activity of Niemann-Pick C1 protein

Drug-induced phospholipidosis: issues and future directions

The role of the VPS4A-exosome pathway in the intrinsic egress route of a DNA-binding anticancer drug

Drug-induced phospholipidosis

Functions of lysosomes

Selective determination of the doxorubicin content of individual acidic organelles in impure subcellular fractions.

The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions.

Lysosomal trapping as an important mechanism involved in the cellular distribution of perazine and in pharmacokinetic interaction with antidepressants.

Simulation-based cheminformatic analysis of organelle-targeted molecules: lysosomotropic monobasic amines.

P304

1445-1459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/BIO.09.128

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47810504

http://www.w3.org/2001/XMLSchema#string

P698

21083094

http://www.w3.org/2001/XMLSchema#string

P932

3065188

http://www.w3.org/2001/XMLSchema#string